Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 11:17 AM 2012  
0151 0322 UL KFT 0220 0506 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for HSP and ACUR ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 Hospira Inc.  and   Acura Pharmaceuticals Inc.
Check Correlation Matrix  
Daily Returns (%)
ACUR  HSP  
Timeline
Considering 30-days investment horizon, Hospira Inc. is expected to under-perform the Acura. But the stock apears to be less risky and, when comparing its historical volatility, Hospira Inc. is 2.76 times less risky than Acura. The stock trades about -0.26 of its potential returns per unit of risk. The Acura Pharmaceuticals Inc. is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 326.00 in Acura Pharmaceuticals Inc. on April 26, 2012 and sell it today you would lose (21.00) from holding Acura Pharmaceuticals Inc. or give up 6.44% of portfolio value over 30 days.

Diversification

Very weak diversification
Overlapping area represents amount of risk that can be diversified away by holding Hospira Inc. and Acura Pharmaceuticals Inc. in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

0.52
 Parameters
Time Period1 Month [change]
DirectionPositive ACUR Moved Up vs HSP
StrengthWeak
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between HSP and ACUR with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between HSP and ACUR to your reader
 
Get social with Correlation between HSP and ACUR
 Share Correlation between HSP and ACUR 
Share Share Correlation between HSP and ACUR
    
    
 
       
Predicted Return Density
Expected Daily Returns   
ACUR  HSP  

Hospira Inc.

 
    
    
Hospira
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Hospira Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Valeant Pharmaceuticals International Inc. vs. Hospira Inc.
Elan Corporation plc vs. Hospira Inc.
Alkermes Inc. vs. Hospira Inc.
PetMed Express Inc. vs. Hospira Inc.
Acura Pharmaceuticals Inc. vs. Hospira Inc.
Flamel Technologies SA vs. Hospira Inc.
  

Acura Pharmaceuticals Inc.

 
    
    
Acura
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Acura Pharmaceuticals Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Valeant Pharmaceuticals International Inc. vs. Acura Pharmaceuticals Inc.
Elan Corporation plc vs. Acura Pharmaceuticals Inc.
Hospira Inc. vs. Acura Pharmaceuticals Inc.
Alkermes Inc. vs. Acura Pharmaceuticals Inc.
PetMed Express Inc. vs. Acura Pharmaceuticals Inc.
Flamel Technologies SA vs. Acura Pharmaceuticals Inc.
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting